Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Cannabisaktien sollten nun den S&P um 60% outperformen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
347 Leser
Artikel bewerten:
(1)

Healthtech company, HealthXL, expands operations with new investment and brings in two new Board members

DUBLIN, Sept. 4, 2019 /PRNewswire/ -- Dublin based HealthXL today announced the completion of an investment round of 2M euros. The announcement was made at their event, the HealthXL Global Gathering at Novartis. The funding comes on the back of rapid global expansion of its market intelligence platform and community and was provided by The 2018 Davy EIIS Fund, which is managed jointly by Davy and BDO.

HealthXL logo

HealthXL operates globally with a list of clientele that includes Novartis, Roche, Pfizer, Merck, Philips, Partners Healthcare, Bupa, Guidewell, Health Catalyst, among others. The investment will be used to continue to grow the teams in Ireland, Portugal and USA.

Sinead Heaney, Partner, BDO commented, "The team at HealthXL have achieved significant success to date demonstrated by the calibre of their clients. This is an impressive company in an exciting space with with highly experienced team. We are delighted to be on board to assist HealthXL achieve its ambitious growth plans in the coming years."

The funding announcement coincides with the expansion of HealthXLs Advisory Board to include Robert Garber, Partner at 7Wire Ventures, and Francesca Wuttke, Chief Digital Officer of Almirall Pharmaceuticals

Francesca Wuttke said, 'HealthXL has extensive background in health technology working with industry experts and all the top guns in the digital health space, but also still has the energy and enthusiasm of a start-up. My experience as a champion for digital in pharma, and health tech investments I have made for pharma has taught me to take notice when one group has the breadth and depth to make this big an impact in digital health."

"I have worked with the HealthXL team for a few years and have been impressed by their level of insight, depth of research and the quality of their network," says Robert. 'They are well positioned to influence the direction and success of digital health on a global scale. As a venture investor who invests solely in these technologies, I look forward to adding my unique perspective and experience to help further the mission of HealthXL," said Robert Garber.

"We are excited to bring these global leaders to Dublin and to have the resources and experience to take our platform and community to the next level," added Martin Kelly (CEO and co-founder).

About HealthXL

Launched in 2014 in Dublin, HealthXL has grown to become the leading market intelligence platform and community for health technology and digital health globally.

MEDIA CONTACT:
Maeve Lyons
+353 83 445 9531
maeve@healthxl.org

Logo - https://mma.prnewswire.com/media/698210/HealthXL_Logo.jpg

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2019 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.